| Global Health Pharma News
https://pharma.news07.01.2022 · Two pharmas closed out 2021 with large M&As. In the biggest deal of the year, Melbourne-based CSL announced last week an all-cash acquisition of Swiss specialty pharma Vifor worth $11.7 billion. The purchase will help “expand our presence in the rapidly growing nephrology market,” CSL’s CEO said in a press release.
Breaking World Pharma News
www.worldpharmanews.comDec 29, 2021 · World Pharma News - one of the world's leading web-based pharmaceutical news publications - is committed to providing and disseminating the most prominent pharmaceutical news and achievements
Pharmaceutical Industry In Russia, Pharma News - PharmProm.Net
https://pharmprom.net11.01.2022 · World Pharma News Gustave Roussy and Anju Software to Accelerate Complex Oncology Clinical Studies 13.01.2022 Anju Software announced that Gustave Roussy, one of the top five cancer research centers in the world and Europe's top-ranked... European Medicines Agency receives application for conditional marketing authorisation for Paxlovid 11.01.2022
Health, Medical & Pharma News - Updated Daily
www.drugs.com › newsJan 10, 2022 · Reata Pharmaceuticals Announces Outcome of FDA Advisory Committee Meeting of Bardoxolone for the Treatment of Patients with Chronic Kidney Disease Caused by Alport Syndrome. PLANO, Texas-- (BUSINESS WIRE) December 8, 2021 -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or... 4 weeks ago New Drug Applications.
News - PharmaTimes
www.pharmatimes.com › newsLatest news Oxford joins consortium to advance quantum drug discovery The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
News - PharmaTimes
www.pharmatimes.com/newsNews - PharmaTimes Latest news NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund. 17th December 2021 Kineret receives positive CHMP opinion for treatment of COVID-19 pneumonia